IO Biotech, Inc. Common Stock
Market Cap
3.5M
Short interest (Mar 31)
3.0%
Net Short (Apr 06 ): 22.6%
Borrow Fee
6.60%
Available Shares
0
Price Chart
Company Overview
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.